J Korean Ophthalmol Soc.  1997 Jun;38(6):949-955.

The Role of Mast Cell in Hyperlaxity of Conjunctiva

Affiliations
  • 1Department of Ophthalmology, School of Medicine, Chung Ang University, Seoul, Korea.
  • 2Department of Pathology, School of Medicine, Chung Ang University, Seoul, Korea.

Abstract

To evaluate pathophysiology of Hyperlaxity of conjunctiva which induces itching, tearing and foreign body sensation, we examed conjunctival specimens of 11 hyperlaxity of conjunctiva patients, 13 pterygium, and 10 normal controls. It is hypothesized that mast cells may influence subconjunctival connective tissue for loosening, long standing edema and induce irreversible tissue destruction during the delelpoment of hyperlaxity of conjunctiva. We did the histologic evaluation, toluidine blue staining for counting mast cells in submucosal connective tissue and alcian blue/safranin staining for distinguisment of two phenotypes of mast cells(1. connective tissue mast cell(CTMC) 2. mucosal mast cell(MMC). We also compared it`s count, distributions with each groups. In normal specimens, the mean mast cell count was 3.5 and CTMC/MMC ratio was 2.0, whereas significant increase was noted in hyperlaxity of conjunctiva patients. Mast cell count and CTMC/MMC ratio were 13.5 and 5.5, in pterygium patients, 11.6 and 5.1 respectively. This result indicates that hyperlaxity of conjunctiva was closely related to the action of mast cell especially CTMC, which may destruct conjunctival architecture. Further evaluation is needed to reveal the role of mast cell in ocular surface disorders.

Keyword

Hyperlaxity of Conjunctiva; Connective Tissue Mast Cell; Mucosal Mast Cell

MeSH Terms

Conjunctiva*
Connective Tissue
Edema
Foreign Bodies
Humans
Mast Cells*
Phenotype
Pruritus
Pterygium
Sensation
Tears
Tolonium Chloride
Tolonium Chloride
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr